Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 5, 2014, Pages

  Kuroki, Marcos T ^a   Fink, Gregory D ^b   Osborn, John W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Alzet minipump; Angiotensin II salt hypertension; iPrecio pump; Plasma angiotensin II; Salt sensitive hypertension

Indexed keywords

ALZET MINIPUMP; ANGIOTENSIN II-SALT HYPERTENSION; IPRECIO PUMP; PLASMA ANGIOTENSIN II; SALT-SENSITIVE HYPERTENSION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; INFUSION PUMPS; INFUSIONS, SUBCUTANEOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84906909906     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00922.2013     Document Type: Article

References (30)

1. Abraham G, Simon G. Autopotentiation of pressor responses by subpressor angiotensin II in rats. Am J Hypertens 7: 269-275, 1994.
2. Brown AJ, Casals-Stenzel J, Gofford S, Lever AF, Morton JJ. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol Heart Circ Physiol 241: H381-H388, 1981.
3. Camara AK, Osborn JL. α-Adrenergic systems mediate chronic central AII hypertension in rats fed high sodium chloride diet from weaning. J Auton Nerv Syst 76: 28-34, 1999.
4. Campbell DJ. Do intravenous and subcutaneous angiotensin II administration increase blood pressure by different mechanisms? Clin Exp Pharmacol Physiol 40: 560-567, 2013.
5. Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol Endocrinol Metab 274: E867-E876, 1998.
6. Charles CJ, Espiner EA, Richards AM, Sybertz EJ. Endopeptidase inhibition in angiotensin-induced hypertension. Effect of SCH 39370 in sheep. Hypertension 26: 89-94, 1995.
7. Cserep G, Abraham G, Tolins JP, Simon G. Different vascular responses to subpressor angiotensin II administration in the mesenteric and renal circulation of rats. Am J Hypertens 9: 385-392, 1996.
8. Csiky B, Simon G. Effect of neonatal sympathectomy on development of angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 272: H648-H656, 1997.
9. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991.
10. Huang BS, Ahmadi S, Ahmad M, White RA, Leenen FHH. Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-"ouabain" pathway. Am J Physiol Heart Circ Physiol 299: H422-H430, 2010.
11. Kerenyi SZ, Hartgraves SL. Premature excess release from the Alzet osmotic pump. Pharmacol Biochem Behav 27: 199-201, 1987.
12. King AJ, Fink GD. Chronic low-dose angiotensin II infusion increases venomotor tone by neurogenic mechanisms. Hypertension 48: 927-933, 2006.
13. King AJ, Novotny M, Swain GM, Fink GD. Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat. Am J Physiol Regul Integr Comp Physiol 294: R1262-R1267, 2008.
14. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension 50: 547-556, 2007.
15. Kuroki MT, Guzman PA, Fink GD, Osborn JW. Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension. Am J Physiol Heart Circ Physiol 302: H763-H769, 2012.
16. Ledwith BJ, Cahill MK, Losse LS, Satiritz SM, Eydelloth RS, Dallob AL, Tanaka WK, Galloway SM, Nichols WW. Measurement of plasma angiotensin II: purification by cation-exchange chromatography. Anal Biochem 213: 349-355, 1993.
17. Lohmeier TE, Lohmeier JR, Haque A, Hildebrandt DA. Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension. Am J Physiol Regul Integr Comp Physiol 279: R1437-R1448, 2000.
18. McBryde FD, Guild S, Barrett CJ, Osborn JW, Malpas SC. Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits. Exp Physiol 92: 831-840, 2007.
19. Osborn JW, Fink GD, Kuroki MT. Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation. Curr Hypertens Rep 13: 221-228, 2011.
20. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9: 228-235, 2007.
21. Osborn JW, Hendel MD, Collister JP, Ariza-Guzman PA, Fink GD. The role of the subfornical organ in angiotensin II-salt hypertension in the rat. Exp Physiol 97: 80-88, 2012.
22. Osborn JW, Olson DM, Guzman P, Toney GM, Fink GD. The neurogenic phase of angiotensin II-salt hypertension is prevented by chronic intracerebroventricular administration of benzamil. Physiol Rep 2: e00245, 2014.
23. Simon G, Abraham G, Cserep G. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension. Am J Hypertens 8: 645-650, 1995.
24. Simon G, Csiky B. Effect of neonatal sympathectomy on the development of structural vascular changes in angiotensin II-treated rats. J Hypertens 16: 77-84, 1998.
25. Simon G, Illyes G, Csiky B. Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure, and time. Hypertension 32: 654-660, 1998.
26. Tan T, Watts SW, Davis RP. Drug delivery: enabling technology for drug Discovery and development. iPRECIO micro infusion pump: programmable, refillable, and implantable. Front Pharmacol 2: 44, 2011.
27. Vieira AA, Nahey DB, Collister JP. Role of the organum vasculosum of the lamina terminalis for the chronic cardiovascular effects produced by endogenous and exogenous ANG II in conscious rats. Am J Physiol Regul Integr Comp Physiol 299: R1564-R1571, 2010.
28. Yoshimoto M, Miki K, Fink GD, King A, Osborn JW. Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension 55: 644-651, 2010.
29. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.
30. Zou LX, Imig JD, von Thun AM, Hymel A, Ono H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension 28: 669-677, 1996.